Insider Transactions in Q4 2022 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
4,000
+0.15%
|
$60,000
$15.19 P/Share
|
|
Dec 16
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$3,000
$12.94 P/Share
|
|
Dec 16
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.04%
|
$13,000
$13.01 P/Share
|
|
Dec 09
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.07%
|
$26,000
$13.11 P/Share
|
|
Dec 02
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$3,250
$13.98 P/Share
|
|
Dec 02
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.04%
|
$13,000
$13.84 P/Share
|
|
Nov 02
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.07%
|
$16,000
$8.79 P/Share
|
|
Oct 14
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.11%
|
$27,000
$9.75 P/Share
|
|
Oct 07
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.07%
|
$18,000
$9.72 P/Share
|